AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01859949 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Genotropin (somatropin)
Description: Genotropin(somatoropin) 12 mg, Genotropin(somatropin) will be given at a dose of 0.067 mg/kg/day or 0.033 mg/kg/day to all participating patients
Study NCT01153009 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vortioxetine
Description: Encapsulated vortioxetine immediate release tablets
Study NCT01153009 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Duloxetine
Description: Overencapsulated duloxetine delayed-release capsules
Study NCT01153009 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo-matching capsules
Study NCT03992378 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low Level Transcutaneous Vagus Nerve Stimulation
Description: Stimulation of the auricular branch of the vagus nerve at tragus of the external ear delivered by Parasym device.
Study NCT03992378 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Low Level Transcutaneous Vagus Nerve Stimulation
Description: Stimulation of the ear lobe delivered by Parasym device.
Study NCT01909960 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Flow imaging
Description: Quantitative flow study was performed by 2D phase-contrast velocity-encoded cine MRI (repetition/echo time, 15/7 ms; field of view = 140 x 140 mm²; matrix size = 256 x 128, flip angle = 25 degrees,one excitation, slice thickness = 5 mm). Cerebrospinal fluid and blood flows are measured with a velocity-encoding value of 5-10 cm/s and 80 cm/s respectively. Peripheral gating was used to cover the entire cardiac cycle with retrospective cardiac synchronization of 32 quantitative flow-encoded images per cycle.~Clinical examination consists in Larson's score and MMSE
Study NCT01305772 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Panitumumab
Description: Single dose Panitumumab 9mg/kg IV (in the vein) prior to definitive therapy (surgery or radiation therapy). Two additional doses of panitumumab 9mg/kg IV may be given at weeks 1 \& 4 of RT alone or weeks 1 \& 4 of cisplatin/RT if they tolerated first dose of panitumumab.
Study NCT01305772 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Panitumumab
Description: Single dose Panitumumab 9mg/kg IV (in the vein) prior to definitive therapy (surgery or radiation therapy). Two additional doses of panitumumab 9mg/kg IV may be given at weeks 1 \& 4 of RT alone or weeks 1 \& 4 of cisplatin/RT if they tolerated first dose of panitumumab.
Study NCT01305772 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgery
Description: Second biopsy was taken from surgical resection tissue (when possible obtained pre and post panitumumab biopsies from the same site).
Study NCT01305772 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Radiation Therapy
Description: Radiation therapy was initiated within 8 weeks after surgery, or as soon as possible.
Study NCT01305772 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: Radiation therapy was initiated within 8 weeks after surgery, or as soon as possible.
Study NCT04557436 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: PBLTT52CAR19
Description: gene therapy
Study NCT04647513 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intradermal injection (superficial dermis for Art Filler Fine Lines / moderately deep to deep dermis for Art Filler Universal and Art Filler Lips)
Description: The function of injectable fillers for the treatment of dermal contour deformities is to smooth dermal depressions formed by the loss of volume and the aging process. These fillers (also known as soft tissue augmentation medical devices) can correct the skin depressions/wrinkles, balance the disproportions or correct topographical anomalies.
Study NCT01115387 — intervention group
Intervention type: OTHER
Intervention: Observational-1
Description: Multiple questionnaires detailing family history, medical history, visual symptoms, smoking, environmental and dietary exposures.~Prospective photography of the retina to detect early ARM-related changes A saliva or blood sample for genetic testing.
Study NCT01115387 — intervention group
Intervention type: OTHER
Intervention: Observational-2
Description: A limited number of questionnaires and prior clinical documentation from eye care professionals of eye status with respect to ARM.~No prospective retina photographs but ongoing follow-up for reported changes in ARM status.~A saliva or blood sample for genetic testing.
Study NCT00858806 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imatinib
Description: Intermittent Imatinib administration.~* 1 week on / 1 week off for the 1st month(weeks 1-4)~* 2 weeks on / 2 weeks off for the 2nd and the 3rd month (weeks 5-12)~* 1 month on / 1 month off from the 4th month thereafter (weeks 13 on)
Study NCT00645372 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Risperidone
Description: Oral risperidone capsules 1 and 2 mg; doses were 1 mg once daily on Days 1-2, 2 mg once daily on Days 3-4, 3 mg once daily on Days 5-7, and 1, 2, or 3 mg twice daily during Weeks 2-6
Study NCT00645372 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ziprasidone
Description: Oral ziprasidone capsules 40, 60, and 80 mg; doses were 40 mg twice daily on Days 1-2, 60 mg twice daily on Days 3-7, and 40, 60, or 80 mg twice daily during Weeks 2-6
Study NCT03373747 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Reliability of IET
Description: The participants will be do three sessions: familiarization, test and retest to assess the reliability inter and intra rater of the test.
Study NCT03373747 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Physiological analysis of IET
Description: The participants will be submitted two sessions, familiarization session and test session. In the test session there will be the physiological analysis by means of gas analysis, blood lactate concentrate and activation muscular percentage.
Study NCT02804048 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: superficial heat pelvic floor muscle
Description: Superficial heat application in the pelvic floor muscle
Study NCT02804048 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: superficial heat low back
Description: Superficial heat application in the low back
Study NCT02804048 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pelvic Floor Muscle Training
Description: Pelvic floor muscle training exercises
Study NCT02804048 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Manual therapy in iliopsoas, diaphragm and piriformis
Description: Manual therapy in iliopsoas, diaphragm and piriformis for 10 minutes
Study NCT02804048 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Manual therapy in iliopsoas, diaphragm and piriformis
Description: Manual therapy in iliopsoas, diaphragm and piriformis for 10 minutes
Study NCT02804048 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intra Vaginal Manual therapy
Description: Intra Vaginal Manual therapy in the pelvic floor muscles
Study NCT02804048 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electromyographic biofeedback
Description: Electromyographic biofeedback in the pelvic floor muscles
Study NCT00546169 — intervention group
Intervention type: DRUG
Intervention: Fibrinogen (human) + thrombin (human) (TachoSil)
Description: haemorrhages in cholecystectomy
Study NCT01156493 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Protein Hydrolyzed Premature Formula
Description: Infants will be fed with a protein hydrolyzed premature formula until they reach full feeds
Study NCT02143024 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family-based depression intervention
Description: The primary focus of our approach is on effectively engaging family members of depressed older men in the care of the patient. The interventionist (social worker) will 1) work jointly with a family member and older men to strengthen depression self-management and participation during primary care visits and 2) conduct a brief training module for primary care provider skills to strengthen their skills in working with family members.
Study NCT02143024 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual care plus educational materials
Description: Control subjects will receive usual care in the clinic augmented by psychoeducation. Family members will be given standard psychoeducational materials on depression.
Study NCT01614444 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Active Acupressure Treatment
Description: Participant will receive 8 active acupressure treatments.
Study NCT01614444 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Acupressure Treatment
Description: Participants will receive 8 placebo acupressure treatments.
Study NCT02861430 — intervention group
Intervention type: PROCEDURE
Intervention: Immunochemistry and molecular biology on sentinel lymph node specimen
Study NCT02991963 — intervention group
Intervention type: OTHER
Intervention: Interview
Description: A survey will be included patient demographics, information on malaria treatment, bed net use and possible risk factors for acquiring malaria, as well as questions about their travel and usage of mobile phones
Study NCT02991963 — intervention group
Intervention type: OTHER
Intervention: Blood collection (Dried Blood Spot)
Description: Dried Blood Spot
Study NCT02991963 — intervention group
Intervention type: OTHER
Intervention: Blood Collection (Venous Blood collection)
Description: Venous Blood collection
Study NCT02991963 — intervention group
Intervention type: OTHER
Intervention: Blood Smear
Description: Slide blood smear
Study NCT03208894 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Furosemide Injection
Description: efficacy of salbutamol and furosemide in TTN
Study NCT00813878 — intervention group
Intervention type: GENETIC
Intervention: protein analysis
Description: protein analysis
Study NCT00813878 — intervention group
Intervention type: GENETIC
Intervention: protein expression analysis
Description: protein expression analysis
Study NCT00813878 — intervention group
Intervention type: GENETIC
Intervention: proteomic profiling
Description: proteomic profiling
Study NCT00813878 — intervention group
Intervention type: OTHER
Intervention: diagnostic laboratory biomarker analysis
Description: Performed one time on study
Study NCT00813878 — intervention group
Intervention type: OTHER
Intervention: immunohistochemistry staining method
Description: Performed one time on study
Study NCT00813878 — intervention group
Intervention type: OTHER
Intervention: liquid chromatography
Description: Performed on samples collected one time on study
Study NCT00813878 — intervention group
Intervention type: OTHER
Intervention: mass spectrometry
Description: Performed on samples collected one time on study
Study NCT00813878 — intervention group
Intervention type: PROCEDURE
Intervention: fine-needle aspiration
Description: Samples collected one time on study at the appointment for fine-needle aspiration where applicable
Study NCT00813878 — intervention group
Intervention type: PROCEDURE
Intervention: needle biopsy
Description: Samples collected one time on study at the appointment for needle biopsy where applicable
Study NCT00813878 — intervention group
Intervention type: PROCEDURE
Intervention: radiomammography
Description: Samples collected one time on study at the appointment for radiomammography where applicable
Study NCT00314808 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dronabinol
Description: Oral route, 5mg PO 2x daily before and during 2 cycles of chemotherapy,2.5mg PO every night when not on chemotherapy
Study NCT00964379 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: intraperitoneal or extraperitoneal colostomy
Description: creation of colostomy
Study NCT05527795 — intervention group
Intervention type: OTHER
Intervention: Frequency and duration of response to adjuvant immunotherapy according to clinical features
Description: * Frequency of relapse to adjuvant immunotherapy according to clinical features~* Duration of relapse as defined by the time (days) between adjuvant immunotherapy onset and relapse date according to clinical features
Study NCT05527795 — intervention group
Intervention type: OTHER
Intervention: Frequency of each type of relapse (i. e. local, distant, unique or multiple) to adjuvant therapy according to clinical features
Description: Percentages of each type of relapse (i. e. local, distant, unique or multiple) according to clinical features
Study NCT05527795 — intervention group
Intervention type: OTHER
Intervention: Duration of relapse-free survival according to clinical features
Description: Duration of relapse-free survival as defined by the time (days) between adjuvant immunotherapy onset and relapse date.
Study NCT05527795 — intervention group
Intervention type: OTHER
Intervention: Duration of overall survival according to clinical features
Description: Duration of relapse-free survival as defined by the time (days) between adjuvant immunotherapy onset and the date of death (irrespectively of the cause) 10 years after inclusion in the study. Alive or lost to follow-up patients will be censored at the date of the last follow-up visit.
Study NCT05527795 — intervention group
Intervention type: OTHER
Intervention: Overall response rate
Description: Response rate to adjuvant immunotherapy and to treatment lines subsequent to relapse. Response rate to adjuvant immunotherapy is defined by the absence of relapse as assessed by the physician following the first year of adjuvant therapy. Response to treatment after relapse is defined as partial or complete response as assessed by the physician following the first year of adjuvant therapy.
Study NCT05527795 — intervention group
Intervention type: OTHER
Intervention: Frequency of adverse events according to clinical features
Description: Rate of adverse events according to their nature and grade (as defined by CTCAE V 5.0) and according to clinical features
Study NCT03103256 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: YHP1701
Description: PO, Once daily (QD), 8 weeks
Study NCT03103256 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: YHR1703
Description: PO, Once daily (QD), 8 weeks
Study NCT03103256 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: YHR1704
Description: PO, Once daily (QD), 8 weeks
Study NCT02667314 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Jigsaw puzzles
Description: Intervention period 1: Participants are asked to solve jigsaw puzzles at home 6 times per week for at least 1 hour over a period of 5 weeks.~Intervention period 2 (voluntary): Participants receive the possibility to solve jigsaw puzzles free-of-charge at home for a period of at least 3 month before the 1.5-year follow-up.
Study NCT02667314 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive health counseling
Description: Cognitive health counseling regarding modifiable risk and protective factors of cognitive decline and dementia at baseline, and four telephone calls for expert monitoring (three calls during the 5-week period between pre- and posttest, and one call 12 month later)
Study NCT02667314 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive health counseling
Description: Cognitive health counseling regarding modifiable risk and protective factors of cognitive decline and dementia at baseline, and four telephone calls for expert monitoring (three calls during the 5-week period between pre- and posttest, and one call 12 month later)
Study NCT03271593 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT01790802 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 2RT nanosecond laser
Description: active laser therapy
Study NCT01790802 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: 2RT nanosecond laser
Description: active laser therapy
Study NCT03207490 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AMADEO
Description: Robot therapy: 1-Degrees-Of-Freedom (1DOFs) robot training for flexion and extention movements of the hand.~Standard rehabilitation therapy includes speech, physical, occupational therapies and group activities
Study NCT00667914 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: geriatric work-up
Description: Pre- and postoperative treatment of hip-fracture patients in an orthogeriatric unit(geriatric evaluation and management)
Study NCT00667914 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Orthopedic care as usual
Description: treatment in ordinary orthopedic unit
Study NCT03058718 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Procalcitonin
Description: The application of antimicrobial agents is determined by PCT results.
Study NCT03058718 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Clinical Experience
Description: The application of antimicrobial agents is determined by clinical experience of doctors.
Study NCT03923777 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Active Surveillance
Description: Agreeing to postpone treatment while continuing with a CT scan surveillance regimen to follow tumor growth. SABR should be offered if either the tumor is >3 cm in size or the VDT decreases to \<400 days.
Study NCT01317498 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Standard Care
Description: CD4, liver function and CBC every 6 months
Study NCT01317498 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Virological Monitoring
Description: Viral Load test every 6 months
Study NCT03758768 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blue light exposure
Description: Light administered through ceiling mounted light emitting diode (LED)-based room lighting.
Study NCT03758768 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Full spectrum light exposure
Description: Light administered through ceiling mounted light emitting diode (LED)-based room lighting.
Study NCT02393131 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Hippocampal avoidance WBRT
Description: Conformal Whole Brain Radiotherapy 30 Gy in 10 fractions with Hippocampal Avoidance using Intensity modulated radiotherapy, Volumetric arc therapy, or Tomotherapy
Study NCT02393131 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Conformal WBRT
Description: Conformal Whole Brain Radiotherapy 30 Gy in 10 fractions with Hippocampal Avoidance using Intensity modulated radiotherapy, Volumetric arc therapy, or Tomotherapy
Study NCT00405015 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rosiglitazone
Description: Rosiglitazone 4 mg bidaily for 8 weeks
Study NCT05227443 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Exercise aerobic training
Description: It is a procedure that is in the form of exercise training as a part of rehabilitation. The patients were subjected to 3 supervised sessions of exercise training / week for a total duration of 6 weeks. The form of training was aerobic intensity exercise that lasts for 15 minutes of continuous exercise. In this intervention, the investigators provide only lower limbs training exercises.
Study NCT05227443 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Upper, lower and breathing (ULB) exercise
Description: It is a procedure that is in the form of exercise training as a part of rehabilitation. The patients were subjected to 3 supervised sessions of exercise training / week for a total duration of 6 weeks. The form of training was aerobic intensity exercise that lasts for 15 minutes of continuous exercise. In this intervention, the investigators provide lower and upper limbs training exercises as well as breathing exercises.
Study NCT03278366 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dancing
Description: Participants in the intervention group will participate in daily dance activities with their teacher by following along with a video created by the dance researchers at Skidmore College. Teachers will be specifically asked to utilize the movement phrases just prior to administering any formal assessment activity within their classroom (tempo may be chosen at teacher's discretion). Furthermore, teachers may choose to utilize the dance phrases as 'brain breaks' at any point throughout their school day.
Study NCT02922465 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: K-877
Study NCT02922465 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Study NCT03159299 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Yo Puedo + mHealth
Description: This intervention is an adapted diabetes self-management education program. Study participants will attend group classes weekly for 6 weeks, and receive daily text messages over 6 months.
Study NCT01563731 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: all approved antihypertensive drugs; all approved statins
Description: All drugs to be used at doses capable of bringing SBP and LDL-C to targets; only doses approved in each country.
Study NCT01563731 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: all approved antihypertensive drugs; all approved statins
Description: All drugs to be used at doses capable of bringing SBP and LDL-C to targets; only doses approved in each country.
Study NCT02357745 — intervention group
Intervention type: PROCEDURE
Intervention: Non surgical periodontal therapy
Description: scaling and root planing
Study NCT00000311 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Buprenorphine
Description: Medication and Behavioral
Study NCT00000311 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: methadone
Description: medication and behavioral
Study NCT03921632 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smiles Matter Oral Health Education Series
Description: Three sessions scheduled 2 weeks apart consisting of 15-20 minutes of didactic learning, 10 minutes of a group/personal exercise, and 10 minutes of questions that the patients have on the topic discussed that day